Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Pediatrix Medical Group, Inc. before investing.

In this article, we go over a few key elements for understanding Pediatrix Medical Group, Inc.’s stock price such as:

• Pediatrix Medical Group, Inc.’s current stock price and volume
• Why Pediatrix Medical Group, Inc.’s stock price changed recently
• Upgrades and downgrades for MD from analysts
• MD’s stock price momentum as measured by its relative strength

About Pediatrix Medical Group, Inc. (MD)

Before we jump into Pediatrix Medical Group, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Want to learn more about Pediatrix Medical Group, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Pediatrix Medical Group, Inc..

Pediatrix Medical Group, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Pediatrix Medical Group, Inc.’s stock price was $26.510.

Pediatrix Medical Group, Inc. is up 0.11% from its previous closing price of $26.480.

During the last market session, Pediatrix Medical Group, Inc.’s stock traded between $26.020 and $26.550. Currently, there are approximately 80.88 million shares outstanding for Pediatrix Medical Group, Inc..

Pediatrix Medical Group, Inc.’s price-earnings (P/E) ratio is currently at 12.8, which is low compared to the Health Care Providers & Services industry median of 26.8. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Pediatrix Medical Group, Inc. Stock Price History

Pediatrix Medical Group, Inc.’s (MD) price is currently up 4.66% so far this month.

During the month of July, Pediatrix Medical Group, Inc.’s stock price has reached a high of $27.940 and a low of $23.870.

Over the last year, Pediatrix Medical Group, Inc. has hit prices as high as $27.940 and as low as $11.840. Year to date, Pediatrix Medical Group, Inc.’s stock is up 23.94%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Pediatrix Medical Group, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there were 0 analysts who downgraded Pediatrix Medical Group, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Pediatrix Medical Group, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Pediatrix Medical Group, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Pediatrix Medical Group, Inc.’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Pediatrix Medical Group, Inc. (MD) by visiting AAII Stock Evaluator.

Relative Price Strength of Pediatrix Medical Group, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, Pediatrix Medical Group, Inc. has a weighted four-quarter relative price strength of 16.18%, which translates to a Momentum Score of 89 and is considered to be Very Strong.

Want to learn more about how Pediatrix Medical Group, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Pediatrix Medical Group, Inc. Stock Price: Bottom Line

As of July 31, 2026, Pediatrix Medical Group, Inc.’s stock price is $26.510, which is up 0.11% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Pediatrix Medical Group, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.